Funding to Accelerate Groundbreaking Research and Development in Stem Cell Therapies Across Maryland COLUMBIA, Md. , Sept. 17, 2024 /PRNewswire/ -- The Maryland Stem Cell Research Commission ( MSCRC ) announces the allocation of approximately $4.
5 million in new grant awards to advance stem cell research and technology. These grants will drive innovative research with the potential to deliver life-saving treatments and transformative cures for patients with a variety of medical conditions. This award has been awarded to 11 accomplished scientists from Maryland -based institutions and companies.
The awardees include researchers from renowned academic institutions such as Johns Hopkins University and the University System of Maryland , as well as pioneering companies such as Therapative Inc. and Caleo Biotechnologies, Inc. Non-profit organizations, including Regenerative Orthopedics and Sports Medicine, LLC are also among the recipients.
The grants will support critical research into treatments for brain diseases such as Alzheimer's and dementia, blindness, autoimmune diseases, inflammatory bowel disease and orthopedic conditions, among others. A portion of the funding is dedicated to collaborative projects between academic institutions and Maryland -based companies. As part of this strategic initiative, researchers and companies can qualify for additional, second-tier funding when they collaborate to advance their innovative projects.
These collaborations aim to bridge the gap.